Therefore, we aimed at better characterizing the intrathecal and systemic immune compartment in LGI1- and CASPR2-AIE in comparison to idiopathic intracranial hypertension (IIH) and multiple sclerosis (MS) disease control patients. The gene discussed is LGI1; the disease is myeloid sarcoma.